We sincerely thank all participants and their caregivers for their meaningful contributions
A.R., a participant in Sugarfits Diabetes Reversal and Management Program, was diagnosed with Type 2 Diabetes and presented with elevated HbA1c, fasting glucose, and body weight at baseline
5-Amino-1MQ doesn't act on appetite, it works by inhibiting NNMT, which shifts cell metabolism toward fat oxidation and muscle preservation
Semaglutide is a transformative obesity medication with Phase 3 data from tens of thousands of participants, FDA approval, proven cardiovascular benefit, and years of real-world use at scale
This is the first stage of your Wegovy weight loss journey, where youll start taking the medication and embark on your new routine